Combination of Neovestitol and Vestitol Modifies the Profile of Periodontitis-Related Subgingival Multispecies Biofilm.
Tatiane Tiemi MacedoLarissa Matias MalavaziGustavo Quilles VargasFrancisco Jerfeson Dos Santos GonçalvesAline Paim de Abreu Paulo GomesManuela Rocha BuenoLucas Daylor Aguiar da SilvaLuciene Cristina FigueiredoBruno Bueno-SilvaPublished in: Biomedicines (2024)
The aim of this study was to evaluate the effect of the combination of neovestitol-vestitol (CNV) compounds obtained from Brazilian red propolis on the microbiological profile of a mature multispecies subgingival biofilm. The biofilm with 32 bacterial species associated with periodontitis was formed for seven days using a Calgary device. Treatment with CNV (1600, 800, 400, and 200 μg/mL), amoxicillin (54 μg/mL), and vehicle control was performed for 24 h on the last day of biofilm formation. Biofilm metabolic activity and DNA-DNA hybridization (checkerboard) assays were performed. The groups treated with CNV 1600 and amoxicillin reduced 25 and 13 species, respectively, compared to the control vehicle treatment ( p ≤ 0.05); both reduced P. gingivalis , while only CNV reduced T. forsythia . When the data from the two treatments (CNV and AMOXI) were compared, a statistically significant difference was observed in 13 species, particularly members of Socransky's orange complex. Our results showed that CNV at 1600 μg/mL showed the best results regarding the metabolic activity of mature biofilms and obtained a reduction in species associated with the disease, such as T. forsythia , showing a better reduction than amoxicillin. Therefore, CNV seems to be a promising alternative to eradicate biofilms and reduce their pathogenicity.
Keyphrases
- biofilm formation
- candida albicans
- pseudomonas aeruginosa
- staphylococcus aureus
- escherichia coli
- single molecule
- cystic fibrosis
- circulating tumor
- genetic diversity
- combination therapy
- high throughput
- deep learning
- machine learning
- newly diagnosed
- electronic health record
- data analysis
- circulating tumor cells
- smoking cessation